BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND FANCD2, FANCD, 2177, ENSG00000144554, FLJ23826, FAD, FACD, FA4, FA-D2, FAD2, DKFZp762A223 AND Prognosis
17 results:

  • 1. Clinicopathological Analysis and Treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single- Center Study.
    Liu X; Gong C; Zhang J; Feng W; Guo Y; Sang Y; Wang C; Chen Y; Wang J; Yu L; Zhang X; Luo Z
    Cancer Res Treat; 2023 Jul; 55(3):1001-1010. PubMed ID: 36915248
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Ferroptosis-based molecular prognostic model for adrenocortical carcinoma based on least absolute shrinkage and selection operator regression.
    Lin C; Hu R; Sun F; Liang W
    J Clin Lab Anal; 2022 Jun; 36(6):e24465. PubMed ID: 35500219
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Potential Biomarker for Triple-Negative breast cancer Invasiveness by Optical Redox Imaging.
    Feng M; Xu HN; Jiang J; Li LZ
    Adv Exp Med Biol; 2021; 1269():247-251. PubMed ID: 33966225
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events.
    Zeng KL; Sahgal A; Tseng CL; Myrehaug S; Soliman H; Detsky J; Atenafu EG; Lee Y; Campbell M; Maralani P; Husain ZA
    Neurosurgery; 2021 Apr; 88(5):971-979. PubMed ID: 33475723
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The role of ALDH1A1 in contributing to breast tumour aggressiveness: A study conducted in an African population.
    Gyan E; Green A; Ahenkorah-Fondjo L; Jackson A; Toss MS; Akakpo PK; Derkyi-Kwarteng L; Rahman GA; Owiredu W
    Ann Diagn Pathol; 2021 Apr; 51():151696. PubMed ID: 33460998
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Characteristics and survival of de novo and recurrent metastatic breast cancer in New Zealand.
    Lao C; Kuper-Hommel M; Elwood M; Campbell I; Edwards M; Lawrenson R
    Breast Cancer; 2021 Mar; 28(2):387-397. PubMed ID: 33044617
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Optical Redox Imaging Detects the Effects of DEK Oncogene Knockdown on the Redox State of MDA-MB-231 breast cancer Cells.
    Wen Y; Xu HN; Privette Vinnedge L; Feng M; Li LZ
    Mol Imaging Biol; 2019 Jun; 21(3):410-416. PubMed ID: 30758703
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [A Case of Encapsulated Papillary Carcinoma of the breast].
    Nakano H; Abe N; Noda M; Sakuyama M; Murakami Y; Hoshi N; Okano M; Tachibana K; Yoshida S; Kiko Y; Hashimoto Y; Moriya T; Ohtake T
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):1869-1871. PubMed ID: 30692381
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Association Between Postoperative Complications After Immediate Alloplastic breast Reconstruction and Oncologic Outcome.
    Mousa M; Barnea Y; Arad U; Inbal A; Klausner J; Menes T
    Clin Breast Cancer; 2018 Aug; 18(4):e699-e702. PubMed ID: 29292182
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Frequent alterations of homologous recombination repair pathway in primary and chemotolerant breast carcinomas: clinical importance.
    Dasgupta H; Mukherjee N; Islam S; Bhattacharya R; Alam N; Roy A; Roychoudhury S; Biswas J; Panda CK
    Future Oncol; 2017 Jan; 13(2):159-174. PubMed ID: 27646721
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. In Vivo Visualization of Stromal Macrophages via label-free FLIM-based metabolite imaging.
    Szulczewski JM; Inman DR; Entenberg D; Ponik SM; Aguirre-Ghiso J; Castracane J; Condeelis J; Eliceiri KW; Keely PJ
    Sci Rep; 2016 May; 6():25086. PubMed ID: 27220760
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Overabundant fancd2, alone and combined with NQO1, is a sensitive marker of adverse prognosis in breast cancer.
    Fagerholm R; Sprott K; Heikkinen T; Bartkova J; Heikkilä P; Aittomäki K; Bartek J; Weaver D; Blomqvist C; Nevanlinna H
    Ann Oncol; 2013 Nov; 24(11):2780-5. PubMed ID: 23897704
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA.
    Volinia S; Galasso M; Sana ME; Wise TF; Palatini J; Huebner K; Croce CM
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3024-9. PubMed ID: 22315424
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Statistical association of basal cell keratins with metastasis-inducing proteins in a prognostically unfavorable group of sporadic breast cancers.
    de Silva Rudland S; Platt-Higgins A; Winstanley JH; Jones NJ; Barraclough R; West C; Carroll J; Rudland PS
    Am J Pathol; 2011 Aug; 179(2):1061-72. PubMed ID: 21801876
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Expression of fancd2 in sporadic breast cancer and clinicopathological analysis.
    Zhang B; Chen R; Lu J; Shi Q; Zhang X; Chen J
    J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):322-5. PubMed ID: 20556575
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Trastuzumab: designer drug or fashionable fad?
    Freebairn AJ; Last AJ; Illidg TM
    Clin Oncol (R Coll Radiol); 2001; 13(6):427-33. PubMed ID: 11824879
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations.
    Gaffney DK; Brohet RM; Lewis CM; Holden JA; Buys SS; Neuhausen SL; Steele L; Avizonis V; Stewart JR; Cannon-Albright LA
    Radiother Oncol; 1998 May; 47(2):129-36. PubMed ID: 9683359
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.